Updated:
Amgen Ventures
Amgen Ventures provides early-stage capital to biotechnology companies developing human therapeutics.
Amgen Ventures
Amgen Ventures was founded in 2004. It functions as a venture fund providing capital to biotechnology companies. The firm pursues early-stage, start-up, expansion, late-stage, and growth investments. It covers venture strategies focused on human therapeutics. Activity centers on North America and the United States. No recent operational events from the last 24 months appear in available records. Team size and additional offices remain undisclosed.
General information
Firm type
Venture Capital
Year founded
2004
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Thousand Oaks
Corporate office
Thousand Oaks, CA, United States
Sector focus
Frequently asked questions
What stages does Amgen Ventures target?
The firm targets early-stage, start-up, expansion, late-stage, and growth investments.
Which sectors receive capital from Amgen Ventures?
Capital flows to biotechnology companies focused on human therapeutics.
Where does Amgen Ventures deploy capital geographically?
Deployments occur across North America and the United States.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: